Detalhe da pesquisa
1.
Targeting TBK1 to overcome resistance to cancer immunotherapy.
Nature;
615(7950): 158-167, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36634707
2.
MLF1 is a proapoptotic antagonist of HOP complex-mediated survival.
Biochim Biophys Acta Mol Cell Res;
1864(4): 719-727, 2017 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28137643
3.
Translational Studies Using the MALT1 Inhibitor (S)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer.
J Immunother Precis Oncol;
6(2): 61-73, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37214210
4.
Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator of mammary gland function.
Mol Cell Biol;
26(15): 5809-26, 2006 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16847333
5.
Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3.
J Physiol Biochem;
71(4): 807-21, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26563351
6.
Both constitutive and inducible prostaglandin H synthase affect dermal wound healing in mice.
Lab Invest;
82(7): 919-27, 2002 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12118094